- Main /
- Company /
- 261-certara

Certara
Health Care Technology
Company websiteFoundation year
2008
Close date
1/7/2021
Profitability
49.83%
About
Total Funding
$389.5M
Certara is the global leader in biosimulation. It accelerates medicines using biosimulation software and technology to transform traditional drug discovery and development. Its clients include more than 1,650 global biopharmaceutical companies, leading academic institutions, and key regulatory agencies across 61 countries. Certara's end-to-end platform includes biosimulation, regulatory science, and market access solutions. It integrates its unique portfolio of software and technology-enabled services spanning discovery to post-approval.
Number of employees
501-1000
Headquarters
Princeton, New Jersey, United States